Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Demonstrating multi-country calibration of a tuberculosis model using new history matching and emulation package - <i>hmer</i>.
Scarponi, D; Iskauskas, A; Clark, R; Vernon, I; McKinley, T; Goldstein, M; Mukandavire, C; Deol, A; WEERASURIYA, C; Bakker, R; WHITE, R; MCCREESH, N;
2022
medRxiv (2022). 10.1101/2022.05.13.22275052.
Vaccines and the social amplification of risk.
LARSON, HJ; LIN, L; Goble, R;
2022
Risk Analysis, (2022).42 7 10.1111/risa.13942.
Challenges and lessons learned during the planning and early implementation of the RTS,S/AS01E malaria vaccine in three regions of Ghana: a qualitative study.
GRANT, J; Gyan, T; Agbokey, F; WEBSTER, J; GREENWOOD, B; ASANTE, KP;
2022
Malaria journal, (2022).21 1 10.1186/s12936-022-04168-9.
Mathematical Modelling for Optimal Vaccine Dose Finding: Maximising Efficacy and Minimising Toxicity.
BENEST, J; Rhodes, S; Evans, TG; WHITE, RG;
2022
Vaccines, (2022).10 5 10.3390/vaccines10050756.
Assessing the impacts of timing on the health benefits, cost-effectiveness and relative affordability of COVID-19 vaccination programmes in 27 African Countries.
LIU, Y; PEARSON, CA B; Madriz Montero, A; TORRES-RUEDA, S; Asfaw, E; Uzochukwu, B; Drake, T; Bergren, E; EGGO, R; RUIZ, F; Ndembi, N; Nonvignon, J; JIT, M; VASSALL, A;
2022
medRxiv (2022). 10.1101/2022.05.09.22274846.
Live-attenuated influenza vaccine effectiveness against hospitalization in children aged 2-6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14-2015/16.
Boddington, NL; MANGTANI, P; Zhao, H; Verlander, NQ; Ellis, J; Andrews, N; Pebody, RG;
2022
Influenza and Other Respiratory Viruses, (2022).16 5 10.1111/irv.12990.
ISIDLSHTM/Model_Size_Selection.
BENEST, J; Rhodes, S; Evans, TG; WHITE, RG;
2022
, Github (2022).
Safety and Immunogenicity of a Two-Dose AD26.ZEBOV, MVA-BN-FILO EBOLA Vaccine Regimen in Infants: A Randomised, Double-Blind, Controlled Trial in Sierra Leone and Guinea. (Abstract, Presentation ref ID951).
CHOI, E; Baiden, F; AFOLABI, M; Foster, J; MANNO, D; Ishola, D; Njie, Y; Lowe, B; Lawal, B; Otieno, GT; GREENWOOD, B; WATSON-JONES, D;
2022
(2022).
Now or later: Health impacts of delaying single-dose HPV vaccine implementation in a high-burden setting.
Burger, EA; Laprise, J-F; Sy, S; Regan, MC; PREM, K; JIT, M; Brisson, M; Kim, JJ;
2022
International Journal of Cancer, (2022).151 10 10.1002/ijc.34054.
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: a modelling study.
Portnoy, A; Clark, R; Quaife, M; WEERASURIYA, C; Mukandavire, C; Bakker, R; Deol, A; Malhotra, S; Gebreselassie, N; Zignol, M; Sim, SY; Hutubessy, RC W; Baena, IG; Nishikiori, N; JIT, M; WHITE, R; Menzies, N;
2022
medRxiv (2022). 10.1101/2022.05.04.22274654.